Legacy Novozymes delivers solid last full-year results
01. Februar 2024 02:00 ET
|
Novozymes A/S
Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth in 2023. This marks...
Results update for 2023 – unaudited
01. Februar 2024 01:59 ET
|
Novozymes A/S
6% organic sales growth in Q4 and 5% for the full year with solid margins and free cash flow generation As Novozymes just closed the combination with Chr. Hansen on January 29, and the annual...
Total number of voting rights and capital on January 31, 2024
31. Januar 2024 08:20 ET
|
Novozymes A/S
Total number of voting rights and capital on January 31, 2024 January 31, 2024Company announcement No. 05 Referring to company announcement 02, on January 29, 2024, where Novozymes A/S...
Trading by management and close relations of management
29. Januar 2024 09:59 ET
|
Novozymes A/S
January 29, 2024Company announcement No. 04 Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on...
Major shareholder announcement
29. Januar 2024 07:13 ET
|
Novozymes A/S
Major shareholder announcement January 29, 2024Company announcement No. 03 On January 29, 2024, following the satisfaction of all conditions precedent, the combination of...
The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner
29. Januar 2024 05:27 ET
|
Novozymes A/S
Today, the proposed combination of the legacy companies Novozymes and Chr. Hansen is successfully completed, establishing the company Novonesis. Novonesis is a world-leading biosolutions partner for...
Completion of the combination between Novozymes and Chr. Hansen
29. Januar 2024 05:25 ET
|
Novozymes A/S
Please read the full announcement in PDF
Attachment
2024_02_Completion_Of_The_Combination
...
All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen
26. Januar 2024 06:06 ET
|
Novozymes A/S
Please read the full announcement in PDF
Attachment
2024_01_All_Regulatory_Approvals_Obtained
...
South Korean merger approval granted
20. Dezember 2023 09:00 ET
|
Novozymes A/S
Please read the full announcement in the attached PDF
Attachment
2023_South Korean merger approval granted
...
Novozymes’ updated financial calendar
13. Dezember 2023 08:46 ET
|
Novozymes A/S
Please read the full announcement in PDF
Attachment
2023_61_Updated_financial_calendar
...